Liraglutide is a medication that belongs to the class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1s). It is primarily used for the treatment of Type 2 Diabetes, but it has also been approved for chronic weight management under a different brand name, called Saxenda®, a daily subcutaneous injection.
Liraglutide mimics the action of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). GLP-1 is produced in the gut and plays a role in regulating blood sugar levels, insulin secretion, and appetite.
As a GLP-1, liraglutide activates GLP-1 receptors which leads to several beneficial effects. It enhances insulin secretion and helps lower blood glucose levels. Liraglutide also reduces the release of glucagon, a hormone that raises blood sugar levels.
In addition to its effects on blood sugar control, liraglutide can contribute to weight management. It slows down gastric emptying, leading to increased feelings of fullness and reduced appetite. This effect can be helpful for individuals who are looking to lose weight or maintain a healthy weight.
You can read the complete medication guide for Saxenda on our website.
Comments
0 comments
Article is closed for comments.